Novare Capital Management LLC Surface Oncology, Inc. Transaction History

Novare Capital Management LLC

  • $1.16 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 04, 2021
SELL
$5.16 - $7.98 $51,600 - $79,800
-10,000 Closed
0 $0
Q1 2021

May 11, 2021
SELL
$7.25 - $13.82 $346,745 - $660,969
-47,827 Reduced 82.71%
10,000 $78,000
Q1 2021

May 07, 2021
BUY
$7.25 - $13.82 $419,245 - $799,169
57,827 New
57,827 $9.17 Million

Others Institutions Holding SURF

# of Institutions
2
Shares Held
315K
Call Options Held
0
Put Options Held
0
View Full List

About Surface Oncology, Inc.

SURF Quotes by TradingView
  • Ticker SURF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,034,000
  • Description
  • Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...
More about SURF
Track This Portfolio

Track Novare Capital Management LLC Portfolio

Follow Novare Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Novare Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Novare Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email